Aimmune Therapeutics climbs, Planet Fitness falls in market debuts

Markets Associated Press

Shares of Aimmune Therapeutics Inc. jumped in their market debut on Thursday, while Planet Fitness' stock declined.

Continue Reading Below

Aimmune, a biopharmaceutical company developing treatments for peanut allergy and other food allergies, raised $160 million from its initial public offering of 10 million shares. The offering priced at $16 per share.

The company is giving the underwriters a 30-day option to buy up to an additional 1.5 million shares.

The stock leapt $5.48, or 34.3 percent, to $21.48 in midday trading on the Nasdaq. It is trading under the "AIMT" ticker symbol.

Elsewhere, Planet Fitness raised $216 million from its IPO of 13.5 million shares. The offering priced at $16 per share.

The fitness center operator and certain selling stockholders are giving the underwriters a 30-day option to buy up to an additional 2 million shares.

Continue Reading Below

Shares of Planet Fitness Inc. shed 20 cents to $15.80. It is listed on the New York Stock Exchange under the "PLNT" ticker symbol.